Days of Our Lives alum Crystal Chappell is sharing a rare update on husband Michael Sabatino's health. "He's doing well," ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Fingernail-sized vibrating gadgets, similar to the tiny devices that make your cellphone buzz, could help people with ...

Legendary ski jumper Jim Holland recalls fondly — and with a bit of amusement — making that first jump (more like a "leap of ...

Thousands of lawsuits cite studies linking paraquat to Parkinson’s disease. The EPA says the evidence doesn't warrant a ban ...

Parkinson’s path to the Canadian national bobsleigh team has been a less travelled route—one that started on a diving ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s diseaseONAPGO is a wearable subcutaneous infusion ...

Growing evidence supports the theory that Parkinson's disease develops in the gut before attacking the central nervous system and brain. To this point, two studies suggest that B vitamins, ...